“Under pressure from government regulators around the world, Bayer announced … that it is suspending global sales of a drug widely used to control bleeding during heart surgery, after a study found that patients receiving the medication were at increased risk of dying compared with those who received two other drugs. U.S., German and Canadian regulators pushed Bayer to stop selling Trasylol until authorities could complete a detailed review of a Canadian study that was halted two weeks ago when a preliminary analysis indicated that those given the medication were more likely to die in the 30 days after the procedures.”Rob Stein, Washington Post, 11-6-07
Bayer Halts Sale of Drug used in Heart Surgery “Trasylol Linked to Deaths After Procedure”
Heart Surgery Drug-Trasylol
